P/E ratio for Align Technology (ALGN)
P/E ratio as of May 2024 (TTM): 57.8
According to Align Technology 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 57.8351. At the end of 2022 the company had a P/E ratio of 45.6.
P/E ratio history for Align Technology from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 45.6 | -32.07% |
| 2021 | 67.2 | 184.06% |
| 2020 | 23.7 | -52.78% |
| 2019 | 50.1 | 19.6% |
| 2018 | 41.9 | -45.52% |
| 2017 | 76.9 | 90.35% |
| 2016 | 40.4 | 10.41% |
| 2015 | 36.6 | 18.43% |
| 2014 | 30.9 | -56.75% |
| 2013 | 71.4 | 165.11% |
| 2012 | 26.9 | -2.36% |
| 2011 | 27.6 | 38.39% |
| 2010 | 19.9 | -146.99% |
| 2009 | -42.4 | -686.73% |
| 2008 | 7.23 | -77.02% |
| 2007 | 31.5 | -223.9% |
| 2006 | -25.4 | -111.78% |
| 2005 | 216 | 200.93% |
| 2004 | 71.7 | -251.93% |
| 2003 | -47.2 | 2480.76% |
| 2002 | -1.83 | 12.11% |
| 2001 | -1.63 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Danaher DHR | 33.0 | -42.90% | 🇺🇸 USA |
 3M MMM | -7.86 | -113.59% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | -28.4 | -149.07% | 🇺🇸 USA |
 Biolase
BIOL | -0.0006 | -100.00% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.